APPLICATIONS PUBLISHED 4 AUGUST 2004
Published: 1-Feb-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Method to induce neovascular formation and tissue regeneration
Sterrenbeld Biotechnologie North America; Fundacion Universitaria DR Rene G Favorolo 1441682*
Trisubstituted triazine compounds, and methods for making and using the compounds. which have antitubulin activity
New York University 1441683*
Methods and compsns for treating urological disorders using 313, 333, 5464, 18817 or 33542
Millennium Pharmaceuticals 1441684*
Anti-rosacea treatment
Color Access 1441685*
Topical cosmetic compsn with skin rejuvenation benefits
Avon Products 1441686*
Powdered material and ceramic material manufactured therefrom
Doxa Aktiebolag 1441687*
Solid oral anti-tartar and anti-plaque compsns
Perfetti Van Melle 1441688*
Solid oral compsns
Perfetti Van Melle 1441689*
Increased peroxide content tooth bleaching gel
Discus Dental 1441690*
Beta-glucuronidase inhibitors for use in deodorants and anti-perspirants
Henkel 1441691*
Compsn containing an amino acid N-acylated ester and a polyamide-structured UV filter
L'Oreal 1441692*
Skin preparation containing a tocopherol derivative for external application
Showa Denko 1441693*
Gastric raft compsn
AstraZeneca 1441694*
Switchable surfaces
Massachusetts Institute of Technology 1441695*
Method and compsn for dry eye treatment
Yissum Research Development Company of the Hebrew University of Jerusalem 1441696*
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
Yale University 1441697*
Flashmelt oral dosage formulation
Bristol-Myers Squibb 1441698*
Powder for nasal administration of drugs
Universita degli studi di Parma 1441699*
Method the preparation of a pharmaceutical compsn comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
Ferring 1441700*
Montelukast granule formulation
Merck Frosst Canada 1441701*
Method for treating primary insomnia
Neurim Pharmaceuticals (1991) 1441702*
System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
Therics; Massachusetts Institute of Technology 1441703*
Orodispensible tablet having high homogeneity and the preparation method thereof
Ethypharm 1441704*
Solid, stabilised, prompt and/or modified release therapeutic systems for the oral administration of liquid active principles, excipients or foodstuffs
Farmatron 1441705*
Antimuscarinic aerosol
Pharmacia & Upjohn 1441706*
Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
Pharmacia 1441707*
Compsns and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
Krele Pharmaceuticals 1441708*
Albuterol inhalation solution, system, kit and method for relieving symptoms of paediatric asthma
Dey LP 1441709*
Use of N,N-diethyl-2--4-(phenylmethyl)-phenoxy ethanamine monohydrochloride (DPPE) in cancer therapy
Vincent Research & Consulting 1441710*
Treatment of breast cancer
The University of Manitoba; Vincent Research & Consulting 1441711*
Reversing or preventing premature vascular senescence
Cornell Research Foundation 1441712*
Modified release tamsulosin tablets
Synthon 1441713*
Combinations comprising a selective cyclooxygenase-2 inhibitor
Novartis 1441714*
Lipoxins and aspirin-triggered lipoxins and their stable analogues in the treatment of asthma and inflammatory airway diseases
The Brigham and Women's Hospital 1441715*
Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
The University Court of the University of Aberdeen 1441716*
Combination of an ATP-competitive inhibitor of BCR/ABL kinase activity and a tyrphostin analogue
Mayo Foundation for Medical Education and Research 1441717*
Carbinols for the treatment of neuropathic dysfunction
Endo Pharmaceuticals 1441718*
N-substituted pyrrolidine derivatives as dipeptidyl peptidase IV inhibitors
F Hoffmann-La Roche 1441719*
Inhibitors of serine protease, particularly hepatitis C virus NS3-NS4A protease, incorporating a fused ring system
Vertex Pharmaceuticals; Pernie, Robert; Pitlik, Janos; Van Drie, John 1441720*
Use of endothelin receptor antagonists in the treatment of tumour diseases
Merck Patent 1441721*
Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases
Bristol-Myers Squibb 1441722*
Use of irebestatin for the preparation of medicaments that are used to treat pulmonary hypertension
Sanofi-Synthelabo 1441723*
Methods of increasing endogenous testosterone levels
Applied Research Systems 1441724*
Benzimidazoles and analogues and their use as protein kinases inhibitors
Aventis Pharmaceuticals 1441725*
Derivatives of phenoxy-N-'4-(isothiazolidin-1,1-dioxid-2yl)phenyl-valerian-acid amide and other compounds as inhibitors of the coagulation factor XA in the treatment of thromboembolic diseases and tumours
Merck Patent 1441726*
Dport formulations of iloperidone and a star polymer
Novartis 1441727*
Modulators of the cholesterol biosynthetic pathway
Vertex Pharmaceuticals 1441728*
Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
SmithKline Beecham 1441729*
Hydrazono-malonitriles
Merck Patent 1441730*
Pyridone, pyridazone and triazone derivatives as LP-PLA2 inhibitors
SmithKline Beecham 1441731*
Thiazole derivative and pharmaceutical use thereof
Fujisawa Pharmaceutical 1441732*
Pharmaceutical compsns for the treatment of leukaemia comprising dioxalane nucleosides analogues
Shire Biochem 1441733*
Dihydroxypyrimidone carboxamide inhibitors of HIV integrase
Istituto di Ricerche di Biologia Moleculare 1441734*
N-substituted hydroxypyrimidone carboxamide inhibitors of HIV integrase
Istituto di Ricerche di Biologia Moleculare 1441735*
Use of 7H-pyrrolo[2,3-D]pyrimidine derivatives in the treatment of solid tumour diseases
Novartis 1441736*
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
Novartis 1441737*
A combination product comprising melagatran and dexamethasone
AstraZeneca 1441738*
Use of (11beta, 17beta)-11-(1m3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
Akzo Nobel 1441739*
Antisense modulation of matrix metalloproteinase 1 expression
Isis Pharmaceuticals 1441740*
Rehydrating formulation
Galactogen Products 1441741*
Axon repair
Duke University; Novartis Forschungsstiftung Zweigniederlassung, Friedrich Miescher Institute for Biomedical Research 1441742*
Methods for treating occular neovascular diseases
Eyetech Pharmaceuticals 1441743*
Improvements in or relating to inhibition of viruses
Medical Research Council 1441744*
Polyacrylate compsns for use in protecting mucosa
Reckitt Benckiser Healthcare 1441745*
Compsns and method
Hill's Pet Nutrition 1441748*
Use of an extract from the Vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical compsn
Cognis France 1441749*
High-concentration protein formulations and method of manufacture
Rxkineticx; The Board of Regents of the University of Colorado 1441748*
Linear and cyclic melanocortin receptor-specific peptides
Palatin Technologies 1441750*
Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischaemic optic neuropathy
Allergan 1441751*
Endophilin homologous proteins involved in the regulation of energy homeostasis
DeveloGen Aktiengesellschaft fuer entwicklungsbiologische Forschung 1441752*
Cell cycle progression proteins
Cyclacel 1441753*
Use of EGF to inhibit pathogenic infections of the urogenital tract
University Technologies International 1441754*
Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
MediGene 1441755*
PSP-99: use for treatment of hypercalcaemia and bone metastasis
Procyon Biopharma 1441756*
Non-neurotoxic plasminogen activating factors for treating stroke
Paion 1441757*
Allogenic vaccine that contains a co-stimulatory polypeptide-expressing tumour cell
MediGene 1441758*
